Ignite Creation Date:
2025-12-24 @ 3:43 PM
Ignite Modification Date:
2025-12-26 @ 9:53 PM
Study NCT ID:
NCT01002092
Status:
UNKNOWN
Last Update Posted:
2014-09-03
First Post:
2009-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Sponsor:
Shandong Simcere-Medgenn Bio-pharmaceutical Co., Ltd
Organization:
Study Overview
Official Title:
A Randomized, Controlled Multicenter Trial of Endostar Combined With Chemotherapy for Treatment of Osteosarcoma
Status:
UNKNOWN
Status Verified Date:
2014-08
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Purpose: This study will assess the safety and efficacy of Endostar combined with chemotherapy in osteosarcoma patients.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: